Effects of Race Pace Based Approach in Recreational Runners (22HUM23661)

January 10, 2024 updated by: Arturo Casado, Universidad Rey Juan Carlos

Effects of Race Pace Based Approach on the Performance of Recreational Runners: a Randomized Controlled Trial

The aim of the study was to compare the performance effects of the intensity demarcation model based on the race pace based approach with the triphasic physiological model and heart rate variability guidelines (HR+HRV)

Study Overview

Detailed Description

After being informed and signing informed consent about the present study, participants were randomly assigned to one of three groups before the intervention phase using a Web-based computer program (www.randomizer.org). Groups were matched on a 1:1:1 basis by gender, age, and performance in an official 10-km race in the previous month. Once selected, participants in the heart rate variability (HRV) group began daily measurements to obtain their personalized parameters.

The groups changed according to the intensity zone demarcation pattern: heart rate (HR), race pace (RP) and HR+HRV. The HR group was considered the active control group, as considered the current best practice according to the current literature in endurance running. A 4-week pre-intervention plus 6-week intervention program was set up.

Participants were assessed in four different sessions, two for laboratory evaluations and two for time trial performance. The first session consisted of a running economy test, and, after at least half an hour of rest, a maximal incremental treadmill run. They familiarised themselves with the training sessions according to their group (i.e., running based on HR, RP or HR+HRV guidelines, respectively).

The HRV4training mobile application (https://www.hrv4training.com) was used to assess HRV for one minute in the morning. The difference in RR intervals between heartbeats is used to calculate HRV. The program then uses this information to calculate the rMSSD and moving average (LnrMSSD7-d), converting the results to a number between 5 and 10. Then, the participant must answer a series of questions including his or her current physical state, sleep quality, muscle soreness, etc. After interpolating these variables, the application shows the subjective value derived from the body's reaction to stresses. As a result, daily indications are given in numerical form, with a range of normality (for HR and HRV) that varies each day depending on how the person reacts to stress. Participants were instructed to take the measurement as soon as they woke up, with an empty bladder, lying down, trying to limit movement, and breathing naturally

Training variables (total time, distance, total time spent in each zone) and Training Impulse (TRIMP) were the same for all groups

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Fuenlabrada, Madrid, Spain, 28943
        • Universidad Rey Juan Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being adults
  • VO2max between 45 and 60 mL·min-1·kg^-1 for men
  • VO2max between 40 and 55 mL·min^-1 for women
  • More than 4 days per week of training frequency
  • Running experience ≥ 2 years
  • Record HR data of all training sessions during the study

Exclusion Criteria:

  • Previous injuries for at least three months
  • Smokers
  • Any cardiovascular condition that compromises health status and participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Heart rate (HR)
Three physiological zones were established according to the results of the treadmill test. The HR group completed training sessions based on HR values and velocities associated with ventilatory thresholds (i.e., Z1, zone 1: intensity zone below the first ventilatory threshold; Z2: zone 2, intensity zone between the first and second ventilatory threshold; Z3: zone 3, intensity zone above the second ventilatory threshold. Runners trained 4 times a week.
Runners ran according to speeds and HR associated with ventilatory thresholds. Z1, zone 1: intensity zone below the first ventilatory threshold; Z2: zone 2, intensity zone between the first and second ventilatory threshold; Z3: zone 3, intensity zone above the second ventilatory threshold.
Other Names:
  • HR
Experimental: Race pace based approach (RP)
For the race pace based approach (RP), intensity zones were established by calculating the percentage of the average speed achieved in the 7-km time trial (TT) and 3 zones were established. Kenneally's model was used to determine the race intensity zones by analyzing 7-km TT performance. Z1 corresponds to less than 80% of race pace, Z2 is between 80-95%, and Z3 corresponds to over 95% of race pace. Runners trained 4 times a week.

Runners ran respecting three intensity zones.

The average speed achieved in the 7-km was calculated. From this, three intensity zones were calculated, adhering to the % of the race pace of the 7-km test.

Z1 corresponds to less than 80% of race pace, Z2 is between 80-95%, and Z3 corresponds to over 95% of race pace

Other Names:
  • RP
Experimental: Heart rate + heart rate variability (HRV)
The HR+HRV group completed training sessions based on HR values and velocities associated with ventilatory thresholds (i.e., Z1, zone 1: intensity zone below the first ventilatory threshold; Z2: zone 2, intensity zone between the first and second ventilatory threshold; Z3: zone 3, intensity zone above the second ventilatory threshold. The training sessions were based on physiological thresholds and daily HRV cues. Runners trained 4 times a week.
Runners completed training sessions based on HR values and velocities associated with ventilatory thresholds (i.e., Z1, zone 1: intensity zone below the first ventilatory threshold; Z2: zone 2, intensity zone between the first and second ventilatory threshold; Z3: zone 3, intensity zone above the second ventilatory threshold. The training sessions were based on physiological thresholds and daily HRV cues. High-intensity training was performed only under optimal HRV conditions, thus only when each participant had HRV values in their reference range. If HRV was not optimal, low-intensity training was prescribed. If HRV was not optimal for two days consecutively, rest was prescribed.
Other Names:
  • HR+HRV

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline of Running Economy
Time Frame: Baseline and after 6 weeks

Tests were performed on the treadmill and respiratory gas analysis was carried out.

The laboratory tests included:

- Running economy (RE) test (ml·kg·km)

RE was measured by running two blocks at constant speeds (7 and 9 km·h^-1 or 8 and 10 km·h^-1, respectively), depending on the subject's level, intensities below the first ventilatory threshold. Each block lasted three minutes.

RE is one of the physiological determinants of endurance performance: an improvement in RE over time indicates an improvement in performance

Baseline and after 6 weeks
Change from Baseline of VO2max
Time Frame: Baseline and after 6 weeks

Tests were performed on the treadmill and respiratory gas analysis was carried out.

The laboratory tests included:

- Maximum oxygen consumption test (VO2max)

After 30 minutes of rest, a maximal incremental test was performed to calculate relative VO2max (ml·kg^-1·min^-1) and absolute VO2max (L·min^-1).

The test started at the last speed of the RE test (9 or 10 km·h^-1), depending on the subject's level. The speed increased continuously by 0.5 km·h-1 every minute until exhaustion. The mean value of the last 30 s of the VO2, a respiratory exchange ratio (RER) >1.05, a HR > 95% of the maximum HR, and an RPE > 18 were the variables considered to calculate the VO2max

VO2max is one of the determinants of endurance performance. The relative VO2max is influenced by weight (at equal VO2max, the runner who weighs less is more advantaged). An improvement in absolute and relative values of VO2max over time indicate an improvement in performance

Baseline and after 6 weeks
Change from Baseline of Maximum aerobic velocity (VAM)
Time Frame: Baseline and after 6 weeks

Tests were performed on the treadmill and respiratory gas analysis was carried out.

The laboratory tests included:

- Maximum aerobic velocity (VAM) in km·h^-1

VAM was calculated as the minimum speed that elicits maximum oxygen consumption.

VAM is one of the physiological determinants of endurance performance. An increase in VAM velocity over time is an indication of improved performance

Baseline and after 6 weeks
Change from Baseline of 7-km Time Trial Performance
Time Frame: Baseline and after 6 weeks

Before and after 6 weeks, the final time achieved in a 7-km time trial performance was calculated for all participants.

The athletes were instructed to achieve their best performance on the 7-km. The test was performed in a 400m regulation athletic track. Verbal encouragement was given to all runners in both tests every 400-m lap.

Participants used the same shoe model in the two tests and were asked not to use stimulants (coffee, tea, etc.). They performed the tests at the same time of day ± (2 hours).

A decrease in the final time in the second test, indicates an improvement in performance

Baseline and after 6 weeks
Change from Baseline of the First Physiological Thresholds (VT1)
Time Frame: Baseline and after 6 weeks

Ventilatory thresholds (VT1 and VT2), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.

Were measured changes in:

- Velocity associated with the first ventilatory threshold (VT1) in km·h^-1

Velocity zones corresponding to VT1 indicates a low intensity zone. An increase over time in VT1 indicates an improvement of the aerobic system

Baseline and after 6 weeks
Change from Baseline of the second Physiological Thresholds (VT2)
Time Frame: Baseline and after 6 weeks

Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.

Were measured changes in:

- Velocity associated with the second ventilatory threshold (VT2) in km·h^-1.

Intensity zones corresponding to VT2 indicates a high intensity zone. An increase over time in VT2 indicates an improvement in the anaerobic system

Baseline and after 6 weeks
Change from baseline in HR associated with the first ventilatory threshold
Time Frame: Baseline and after 6 weeks

Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.

were measured changes in:

- HR associated with the first ventilatory threshold HR-VT1 in beats per minute (bpm).

A lower HR associated with VT1, indicates an improvement of the aerobic system over time

Baseline and after 6 weeks
Change from baseline in HR associated with the second ventilatory threshold
Time Frame: Baseline and after 6 weeks

Ventilatory thresholds (VT), measured by gas analysis, are some of the determinants of endurance performance, along with running economy and VO2max.

were measured changes in:

- HR associated with the second ventilatory threshold (HR-VT12) in beats per minute (bpm).

Higher HR associated with VT2, indicates an improvement of the anaerobic system over time

Baseline and after 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Rate of Perceived Exertion (RPE) scale after 6 weeks protocol
Time Frame: Baseline and after 6 weeks

Participants indicated Rating of perceived exertion (RPE) using Borg's 6-20 validated scale, an exertion perception scale used during laboratory testing. RPE values were measured for both the running economy and during the incremental maximal test (VO2max).

The RPE values are:

6. = no exertion at all 7. = extremely light 9. = very light 11. = light 13. = somewhat hard 15. = hard (heavy) 17. = very hard 19. = extremely hard A decrease in RPE over time for the same intensity (e.g., same speed achieved in tests) indicates better performance adaptation

Baseline and after 6 weeks
Changes in Body Weight
Time Frame: Baseline and after 6 weeks

Participants were weighed before and after the study to calculate body composition analysis. Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).

it was measured:

- Body weight (kg)

Baseline and after 6 weeks
Changes in Height (cm)
Time Frame: Baseline and after 6 weeks

Participants were weighed before and after the study to calculate body composition analysis.

Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).

it was measured:

- Height (cm)

Baseline and after 6 weeks
Changes in BMI (kg/m^2)
Time Frame: Baseline and after 6 weeks

Participants were weighed before and after the study to calculate body composition analysis:

Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).

it was measured:

- BMI (kg/m^2)

Baseline and after 6 weeks
Changes in Fat mass
Time Frame: Baseline and after 6 weeks

Participants were weighed before and after the study to calculate body composition analysis:

Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).

it was measured:

- Fat mass (%)

Baseline and after 6 weeks
Changes in Free Fat Mass
Time Frame: Baseline and after 6 weeks

Participants were weighed before and after the study to calculate body composition analysis:

Participants arrived well hydrated, and were instructed to eat at least two hours beforehand. Weighing was performed at the same time slot (± 2 hours).

it was measured:

- Free fat mass (%)

Baseline and after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Arturo Casado, PhD, Centro de Investigación en Ciencias del Deporte
  • Study Director: Alfonso Jiménez Gutiérrez, PhD, Director del Centro de Investigación en Ciencias del Deporte

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2023

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

July 15, 2023

Study Registration Dates

First Submitted

December 21, 2023

First Submitted That Met QC Criteria

January 10, 2024

First Posted (Actual)

January 22, 2024

Study Record Updates

Last Update Posted (Actual)

January 22, 2024

Last Update Submitted That Met QC Criteria

January 10, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 1201202302023
  • 22HUM-23661 (Other Grant/Funding Number: Comunidad Autonoma de Madrid (CAM))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Heart rate (HR)

Subscribe